SW
CLB icon

SVB Wealth’s Core Laboratories CLB Stock Holding History

SVB Wealth’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,929
Closed -$202K – 526
2019
Q1 		$202K Buy
+2,929
New +$196K 0.01% 381
2018
Q4 		– Sell
-3,632
Closed -$421K – 409
2018
Q3 		$421K Sell
3,632
-445
-11% -$50.2K 0.01% 352
2018
Q2 		$515K Sell
4,077
-64
-2% -$7.79K 0.02% 326
2018
Q1 		$448K Buy
4,141
+506
+14% +$56K 0.02% 350
2017
Q4 		$398K Buy
3,635
+106
+3% +$10.6K 0.02% 368
2017
Q3 		$348K Buy
+3,529
New +$342K 0.01% 383

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SVB Wealth's CLB Position: Q2 2019 in Review

SVB Wealth sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 2,929 shares — an estimated $202K sold.

SVB Wealth first reported a position in CLB in Q3 2017 and held it in 6 quarters. The position peaked at $515K in Q2 2018. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

  • SVB Wealth reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
  • SVB Wealth sold 2,929 Core Laboratories shares in Q2 2019, an estimated $202K.
  • SVB Wealth first reported a position in Core Laboratories in Q3 2017 and held it in 6 quarters.
  • SVB Wealth's Core Laboratories position peaked at $515K in Q2 2018.
  • 304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on SVB Wealth's 13F filing for Q2 2019, filed 10 Jul 2019.